- Symbiosis Pharmaceutical Services has appointed Wendy Cook as a Qualified Person (QP).
- The appointment follows regulatory approval of its new GMP facility and automated sterile fill/finish line.
Symbiosis Pharmaceutical Services, a global CMO specialising in the sterile manufacture of injectable drug products, has appointed Wendy Cook as a Qualified Person (QP).
Cook brings more than two decades of pharmaceutical quality assurance experience, covering GLP, GCP and GMP environments. Since qualifying as a QP in 2018, she has worked at both CDMOs and global CMOs, overseeing batch certification, regulatory submissions and quality oversight across multiple dosage forms, including sterile injectables.
The new appointment comes after Symbiosis completed a successful MHRA inspection of its 20,000 sq.-ft. GMP facility, which recently added an automated sterile fill/finish line to its commercial operations.
Nicola Paterson, Lead QP at Symbiosis, said: “Wendy’s appointment strengthens our QP team at a pivotal time for Symbiosis. Her knowledge of GMP, regulatory expectations and sterile manufacturing adds significant expertise to our quality leadership.”
